Twist Bioscience Corp

TWST

Company Profile

  • Business description

    Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

  • Contact

    681 Gateway Boulevard
    South San FranciscoCA94080
    USA

    T: +1 800 719-0671

    https://www.twistbioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 September 2026

    Employees

    979

Stocks News & Analysis

stocks

Nvidia earns upgrade as AI buildouts accelerate

Demand for AI infrastructure shows no signs of slowing.
stocks

Weekly earnings wrap: FMG, WDS, COL and more

A closer look at the final major results from August reporting season.
stocks

Chart of the Week: Are US mega-cap stocks undervalued?

Opportunities emerge across US equities.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,243.2084.80-0.91%
CAC 408,319.87142.52-1.68%
DAX 4026,367.2481.280.31%
Dow JONES (US)53,618.51154.630.29%
FTSE 10010,792.5485.58-0.79%
HKSE25,565.7487.23-0.34%
NASDAQ26,481.05350.851.34%
Nikkei 22566,131.98130.18-0.20%
NZX 50 Index13,880.05133.16-0.95%
S&P 5007,724.1848.480.63%
S&P/ASX 2009,038.2078.20-0.86%
SSE Composite Index3,956.5744.051.13%

Market Movers